107 related articles for article (PubMed ID: 8249432)
1. Further studies on the adjuvanticity of stearyl tyrosine and ester analogues.
Penney CL; Ethier D; Dionne G; Nixon-George A; Zaghouani H; Michon F; Jennings H; Bona CA
Vaccine; 1993; 11(11):1129-34. PubMed ID: 8249432
[TBL] [Abstract][Full Text] [Related]
2. Further studies on the adjuvanticity of stearyl tyrosine and amide analogues.
Penney CL; Dionne G; Nixon-George A; Bona CA
Vaccine; 1994 May; 12(7):629-32. PubMed ID: 8085381
[TBL] [Abstract][Full Text] [Related]
3. Adjuvanticity of stearyl tyrosine on the antibody response to peptide 503-535 from HIV gp160.
Nixon A; Zaghouani H; Penney CL; Lacroix M; Dionne G; Anderson SA; Kennedy RC; Bona CA
Viral Immunol; 1992; 5(2):141-50. PubMed ID: 1616585
[TBL] [Abstract][Full Text] [Related]
4. Adjuvanticity of stearyl tyrosine on inactivated poliovirus vaccine.
Landi S; Penney CL; Shah P; Hart F; Campbell JB; Cucakovich N
Vaccine; 1986 Jun; 4(2):99-104. PubMed ID: 3014774
[TBL] [Abstract][Full Text] [Related]
5. The adjuvant effect of stearyl tyrosine on a recombinant subunit hepatitis B surface antigen.
Nixon-George A; Moran T; Dionne G; Penney CL; Lafleur D; Bona CA
J Immunol; 1990 Jun; 144(12):4798-802. PubMed ID: 2351829
[TBL] [Abstract][Full Text] [Related]
6. Comparison of adjuvant activities of aluminium phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid.
Gupta RK; Siber GR
Biologicals; 1994 Mar; 22(1):53-63. PubMed ID: 8068314
[TBL] [Abstract][Full Text] [Related]
7. Adjuvanticity of stearyl tyrosine on the antibody response to peptide 503-535 from HIV gp160.
Bona C; Nixon A; Kennedy R; Zaghouani H
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1377. PubMed ID: 1466959
[No Abstract] [Full Text] [Related]
8. Impact of antigens, adjuvants and strains on sexually dimorphic antibody response to vaccines in mice.
Li X; Guo S; Yang L; Hua L; Li Z; Hao X; Yu Y; Sun W; Wang L
Biologicals; 2017 Jul; 48():47-54. PubMed ID: 28596048
[TBL] [Abstract][Full Text] [Related]
9. Stearyl tyrosine. An organic equivalent of aluminum-based immunoadjuvants.
Penney C
Pharm Biotechnol; 1995; 6():611-24. PubMed ID: 7551239
[No Abstract] [Full Text] [Related]
10. Enhancement of humoral immune responses against viral vaccines by a non-pyrogenic 6-O-acylmuramyldipeptide and synthetic low toxicity analogues of lipid A.
Tsujimoto M; Kotani S; Okunaga T; Kubo T; Takada H; Kubo T; Shiba T; Kusumoto S; Takahashi T; Goto Y
Vaccine; 1989 Feb; 7(1):39-48. PubMed ID: 2718605
[TBL] [Abstract][Full Text] [Related]
11. Epitope polarity and adjuvants influence the fine specificity of the humoral response against Semliki Forest virus specific peptide vaccines.
Fernández IM; Harmsen M; Benaissa-Trouw BJ; Stuij I; Puyk W; Meloen RH; Snippe H; Kraaijeveld CA
Vaccine; 1998 Oct; 16(16):1531-6. PubMed ID: 9711800
[TBL] [Abstract][Full Text] [Related]
12. [Enhancement of the activity of hepatitis B virus vaccine by association with murabutide].
Audibert F; Przewlocki G; Lefrancier P; Choay J; Chedid L
C R Seances Acad Sci III; 1982 Nov; 295(10):611-4. PubMed ID: 6218866
[TBL] [Abstract][Full Text] [Related]
13. Peptides and their constituent amino acids influence the immune response and phagocytosis in different ways.
Belokrylov GA; Popova OYa ; Molchanova IV; Sorochinskaya EI; Anokhina VV
Int J Immunopharmacol; 1992 Oct; 14(7):1285-92. PubMed ID: 1452413
[TBL] [Abstract][Full Text] [Related]
14. Sucrose fatty acid sulphate esters as novel vaccine adjuvants: effect of the chemical composition.
Blom AG; Hilgers LA
Vaccine; 2004 Dec; 23(6):743-54. PubMed ID: 15542198
[TBL] [Abstract][Full Text] [Related]
15. Effects of muramyl dipeptide derivatives as adjuvants on the induction of antibody response to recombinant hepatitis B surface antigen.
Tamura M; Yoo YC; Yoshimatsu K; Yoshida R; Oka T; Ohkuma K; Arikawa J; Azuma I
Vaccine; 1995 Jan; 13(1):77-82. PubMed ID: 7762283
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism of action of adjuvants].
Vorob'ev AA
Usp Sovrem Biol; 1969; 68(1):72-89. PubMed ID: 4903293
[No Abstract] [Full Text] [Related]
17. Alkyl-esters of polyacrylic acid as vaccine adjuvants.
Hilgers LA; Nicolas I; Lejeune G; Dewil E; Strebelle M; Boon B
Vaccine; 1998 Oct; 16(16):1575-81. PubMed ID: 9711806
[TBL] [Abstract][Full Text] [Related]
18. PCPP as a parenteral adjuvant for diverse antigens.
Payne LG; Van Nest G; Barchfeld GL; Siber GR; Gupta RK; Jenkins SA
Dev Biol Stand; 1998; 92():79-87. PubMed ID: 9554261
[TBL] [Abstract][Full Text] [Related]
19. Production of antibodies recognizing a hepatitis B virus (HBV) surface antigen by administration of murabutide associated to a synthetic pre-S HBV peptide conjugated to a toxoid carrier.
Przewlocki G; Audibert F; Jolivet M; Chedid L; Kent SB; Neurath AR
Biochem Biophys Res Commun; 1986 Oct; 140(2):557-64. PubMed ID: 3778467
[TBL] [Abstract][Full Text] [Related]
20. GD3/proteosome vaccines induce consistent IgM antibodies against the ganglioside GD3.
Livingston PO; Calves MJ; Helling F; Zollinger WD; Blake MS; Lowell GH
Vaccine; 1993 Sep; 11(12):1199-204. PubMed ID: 8256501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
